¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"band of external granular layer"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • A band
    ¾îµÎ¿î¶ì, A¶ì
  • anisotropic band
    ¾îµÎ¿î¶ì
  • anogenital band
    Ç×¹®»ý½Ä¶ì
  • arch and band appliance
    Ȱ¶ìÀåÄ¡
  • amniotic band syndrome
    ¾ç¸·¶ìÁõÈıº
  • anchor band
    Ä¡¾Æ°íÁ¤¶ì
  • belly band
    º¹´ë
  • band
    ¶ì
  • band clasp
    ¶ì°¥°í¸®
  • band neutrophil
    ¶ìÁß¼º±¸
  • band-shaped keratopathy
    ¶ì¸ð¾ç°¢¸·º´(Áõ), ´ë»ó°¢¸·º´(Áõ)
  • collagen band
    ¾Æ±³Áú¶ì
  • congenital constriction band
    ¼±ÃµÇùÂø¶ì
  • cowhorn band
    ¼è»Ô¶ì
  • calf band
    ÀåµýÁö¹êµå, ÀåµýÁö¶ì
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • spinous layer
    °¡½ÃÃþ
  • spongy layer
    ÇØ¸éÃþ
  • submucous layer
    Á¡¸·¹ØÃþ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • granular endoplasmic reticulum
    °ú¸³¼¼Æ÷Áú±×¹°, °ú¸³¼¼Æ÷Áú¼¼¸Á
  • A band
    ¾îµÎ¿î¶ì
  • amniotic band syndrome
    ¾ç¸·¶ìÁõÈıº
  • anchor band
    (¢¡orthodontic band) Ä¡¾Æ°íÁ¤¶ì
  • anisotropic band
    (¢¡A band) ¾îµÎ¿î¶ì
  • anogenital band
    Ç×¹®»ý½Ä¶ì
  • arch and band appliance
    Ȱ¶ìÀåÄ¡
  • band
    ¶ì
  • bacillary band
    »ù¼¼Æ÷¶ì
  • band clasp
    ¶ì°¥°í¸®
  • band crown
    ´ëȯ°ü
  • band neutrophil
    ¶ìÈ£Áß±¸
  • band splint
    ¶ìµ¡´ë, ¶ìºÎ¸ñ
  • band-shaped keratopathy
    ¶ì¸ð¾ç°¢¸·º´Áõ
  • belly band
    º¹´ë
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Granular cortex
    °ú¸³ÇÇÁú(Ψأù«òõ)
  • granular
    °ú¸³¼º(Ψí£àõ)ÀÇ.
  • granular
    °ú¸³¼ºÀÇ
  • granular appendicitis
    °ú¸³¼º Ãæ¼ö¿°.
  • granular atrophy of kidney
    ½ÅÀå°ú¸³¼ºÀ§Ãà.
  • granular basal cell carcinoma
    °ú¸³ ±âÀú¼¼Æ÷¾Ï
  • granular cast
    °ú¸³¿øÁÖ(¡­ê­ñº).
  • granular cast
    °ú¸³¿øÁÖ
  • granular cell
    °ú¸³¼¼Æ÷.
  • granular cell myoblastoma
    °ú¸³¼¼Æ÷±Ù¸ð¼¼ Æ÷Á¾(¡­á¬øàÐÉÙ½á¬øàðþ)
  • granular cell schwannoma
    °ú¸³¼¼Æ÷ ½´¹Ý¼¼Æ÷Á¾
  • granular cell tumo(u)r
    °ú¸³¼¼Æ÷ Á¾¾ç
  • granular pits ; foveolae granulares
    °ú¸³¿À¸ñ, °ú¸³¼Ò¿Í.
  • granular reticulum
    °ú¸³ÇüÁú³»¼¼¸Á(Ψí£û¡òõ Ò®á¬ØÑ), °ú¸³¼º ¼¼¸Á(¡­á¬ØÑ).
  • granular stool
    °ú¸³»ó ´ëº¯.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • band of internal pyramidal layer
    ¼ÓÇǶó¹ÔÃþ¼¶À¯ÁÙ
  • band of molecular layer
    ºÐÀÚÃþ¼¶À¯ÁÙ
  • intermediate layer spinous layer
    Áß°£Ãþ °¡½ÃÃþ
  • internal nuclear layer bipolar cell layer
    ¼ÓÇÙÃþ µÎ±Ø¼¼Æ÷Ãþ
  • molecular layer plexiform layer
    ºÐÀÚÃþ
  • piriform neuron layer [purkinjes layer]
    Á¶·Õ¹ÚÃþ
  • piriform neuron layer[purkinjes layer]
  • piriform neuron layer[purkinjes layer]
  • spinous layer = prickle layer
    °¡½ÃÃþ
  • external layer
    ¹Ù±ùÆÇ
  • external longitudinal layer
    ¹Ù±ù¼¼·ÎÃþ
  • external pyramidal layer
    ¹Ù±ùÇǶó¹Ô¼¼Æ÷Ãþ
  • external pyramidal layer
    ¹Ù±ùÇǶó¹ÔÃþ
  • contagious granular vaginitis
    Àü¿°¼º °ú¸³Áú¿°(îîæøàõΨí£òóæú).
  • granular
    °ú¸³¼ºÀÇ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Granular lutein cell
    °ú¸³ÃþȲ(»ö)ü¼¼Æ÷
    [¿¾ ¿ë¾î] °ú¸³ÃþȲü¼¼Æ÷
  • External longitudinal layer
    ¹Ù±ù¼¼·ÎÃþ
    [¿¾ ¿ë¾î] ¿ÜÁ¾ÁÖÃþ
  • External layer
    ¹Ù±ùÆÇ
    [¿¾ ¿ë¾î] ¿ÜÆÇ
  • External pyramidal layer
    ¹Ù±ùÇǶó¹Ô¼¼Æ÷Ãþ
    [¿¾ ¿ë¾î] ¿ÜÃßü¼¼Æ÷Ãþ
  • External pyramidal layer
    ¹Ù±ùÇǶó¹ÔÃþ
    [¿¾ ¿ë¾î] ¿ÜÇǶó¹ÔÃþ
  • Molecular layer [Plexiform layer]
    ºÐÀÚÃþ
    [¿¾ ¿ë¾î] ºÐÀÚÃþ
  • Internal nuclear layer [Bipolar cell layer]
    ¼ÓÇÙÃþ [µÎ±Ø¼¼Æ÷Ãþ]
    [¿¾ ¿ë¾î] ³»ÇÙÃþ(À̱ؼ¼Æ÷Ãþ)
  • Piriform neuron layer [Purkinje`s layer]
    Á¶·Õ¹ÚÃþ
    [¿¾ ¿ë¾î] Á¶·Õ¹ÚÃþ
  • Intermediate layer [Spinous layer]
    Áß°£Ãþ [°¡½ÃÃþ]
    [¿¾ ¿ë¾î] À¯±ØÃþ
  • (External occipital crest)
    (¹Ù±ùµÚÅë¼ö»À´É¼±)
    [¿¾ ¿ë¾î] ¿ÜÈĵθª
  • Hairs of external acoustic meatus
    ±ÍÅÐ
    [¿¾ ¿ë¾î] À̸ð
  • Orifice of external acoustic meatus
    ±Ó±¸¸Û
    [¿¾ ¿ë¾î] ¿ÜÀ̰ø
  • EXTERNAL GENITAL ORGAN OF MALE
    ³²¼º¹Ù±ù»ý½Ä±â°ü
    [¿¾ ¿ë¾î] ³²¼º¿Ü»ý½Ä±â
  • External plate of optic cup
    ´«¼úÀܹٱùÆÇ
    [¿¾ ¿ë¾î] ¾È¹è¿ÜÆÇ
  • External wall of cochlear duct
    ´ÞÆØÀ̰ü¹Ù±ùº®
    [¿¾ ¿ë¾î] ¿Í¿ì°ü¿Üº®
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • H band
    H ¶ì
  • I band
    I ¶ì
  • isotropic band
    µ¿¹æ¼º(ÔÒÛ°àõ) ¶ì
  • main band DNA
    ÁÖ´ë(ñ«Óá) RNA
  • Racker band
    ¶óÄ¿ ¶ì
  • Soret band
    ¼Ò·¹ ¶ì
  • barrier layer cell
    À庮Ãþ(î¡Ûúöµ) ¼¼Æ÷(á¬øà)
  • bimolecular layer
    À̺ÐÀÚÃþ(ì£ÝÂí­öµ)
  • coupled layer chromatography
    °ø¿ªÃþ(Íëæµöµ) Å©·Î¸¶Åä±×·¡ÇÇ
  • double layer
    ÀÌÁßÃþ(ì£ñìöµ) (ÔÒ) ionic double layer
  • electric double layer
    Àü±â(ï³Ñ¨)
  • feeder layer
    °ø±ÞÀÚÃþ(ÍêÐåíºöµ)
  • germ layer
    ¹è¿±(ÛÏç¨)
  • gradient layer
    ±¸¹èÃþ(ÎþÛÕöµ)
  • half-value layer
    ¹Ý°¨Ãþ(ÚâÊõöµ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
ER efficiency ratio; epigastric region; ejection rate; electroresection; emergency room; endoplasmic re...
APGL alkaline phosphatase activity of granular leukocytes
CDGG corneal dystrophy Groenouw type, granular
EGM electrogram; extracellular granular material
GC ganglion cell; gas chromatography; general circulation; general closure; general condition; generali...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
EPL external plexiform layer
ABS Amniotic Band Syndrome
CK-MB Creatine kinase-myocardial band
DBB Diagonal Band of Broca
DIB diffuse interstellar band
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • cellular proliferative layer
    ¼¼Æ÷¼º Áõ½ÄÃþ
    ¼¼Æ÷ÀÇ µ¿ÀÏÇüÅÂÀÇ Àç»ý»ê ¶Ç´Â Áõ½ÄÃþ.
  • choroid layer
    ¸Æ¶ô¸· Ãþ
    Ç÷°üÀ» °¡Áø ¾È±¸ÀÇ Ãþ.
  • compact layer
    Ä¡¹Ð Ãþ
  • double layer
    ÀÌÁß Ãþ
  • double layer fluorescent antibody technique
    ÀÌÃþ Çü±¤ Ç×ü¹ý
  • external absorption
    ¿ÜÈí¼ö
  • external acoustic meatus
    ¿ÜÀ̵µ
  • external analgesic treatment
    ¿ÜÀμº ÁøÅë ¿ä¹ý, ¿ÜÀμº ÁøÅë Ä¡·á
  • external auditory canal reflex
    ¿ÜÀ̵µ ¹Ý»ç
  • external auditory meatus
    ¿ÜÀ̵µ
  • external barotrauma
    ¿ÜÀμº ¾Ð·Â »óÇØ
  • external callus
    ¿Ü°¡°ñ
  • external carotid artery
    ¹Ù±ù ¸ñµ¿¸Æ, ¿Ü°æ µ¿¸Æ
  • external carotid plexus
    ¹Ù±ù¸ñ µ¿¸Æ ½Å°æ ¾ó±â, ¿Ü°æµ¿¸ÆÃÑ
  • external cloacal fovea
    ¹è¼³°­ ¹Ù±ù ¿À¸ñ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
granular kidney A kidney in which fairly uniform, diffusely and evenly situated foci of scarring of the interstitial tissue of the cortex (and sometimes scarring of glomeruli), and the associated slight degree of bulging of groups of dilated tubules, leads to the development of a minutely bosselated surface; such kidney's are seen in arteriolar nephrosclerosis or chronic glomerulonephritis.
Synonym: sclerotic kidney.
(05 Mar 2000)
granular layers of cerebral cortex Layers 2 (outer) and 4 (inner) of the cortex cerebri.
(05 Mar 2000)
granular layers of retina The outer nuclear layer, layer 4, of the retina, neuroepithelial layer of retina, and the inner layer, layer 6, of the retina, ganglionic layer of retina.
Synonym: granular layers of retina, stratum nucleare externum et internum retinae.
(05 Mar 2000)
granular leukoblast An obsolete term for promyelocyte.
(05 Mar 2000)
granular leukocyte Any one of the polymorphonuclear leukocyte's, especially a neutrophilic leukocyte.
See: granulocyte, basophilic leukocyte, eosinophilic leukocyte.
(05 Mar 2000)
granular lids <ophthalmology> A chronic infectious disease of the conjunctiva and cornea, producing photophobia, pain, lacrimation and blindness.
It is one of the oldest infectious diseases known to mankind, and dates back several thousand years with first documentation as early as the pharaonic era in Egypt.
The disease is associated with poor socioeconomic conditions in general: with overcrowding, poor personal and environmental hygiene and, in particular, with very limited access to water and sanitation. Trachoma has been eliminated as a blinding disease from several previously hyperendemic countries and regions, both through significant improvements in the socioeconomic status of populations and through specific control efforts.
Despite these successes, in many least developed countries of the world blinding trachoma continues to be an important public health problem. In some of the countries where trachoma was once hyperendemic, there remain residual pockets of blinding trachoma and complications, such as inturned eyelashes (trichiasis), which require eyelid surgery.
Today, the disease is found mainly in poor rural areas, including parts of central and south America, most African countries and some countries in the Eastern Mediterranean. Trachoma is still endemic in several Asian countries, but there is a lack of updated information from some major populations, e.g. In India and China.
The organism that causes this disease is Chlamydia trachomatis; a microorganism resembling both bacteria and viruses, which spreads through contact with eye discharge from the infected person (on towels, handkerchiefs, fingers, etc.) and through transmission by eye-seeking flies. Chlamydia trachomatis provokes an inflammatory reaction in the eye with formation of follicles in the conjunctiva. After years of repeated infections, the inside of the eyelids may be scarred so severely that the eyelid turns inwards with eyelashes rubbing on the eyeball. If untreated, this condition leads to blindness.
The World Health Organization is working towards global elimination of trachoma, which is responsible, at present, for at least 15% of the world's blindness. Worldwide, there are about 6 million people largely irreversibly blinded by trachoma, and an estimated 146 million cases of active disease in need of treatment, if blindness is to be prevented.
International efforts to eliminate trachoma as a blinding disease will be based on a combination of interventions known by the acronym "SAFE", which stands for Surgery for trichiasis (inturned eyelashes), Antibiotics, Facial cleanliness and Environmental improvement. These interventions will be community-targeted and will seek community involvement through the primary health care approach.
Origin: Gr. Trachoma = roughness
(07 May 1998)
granular ophthalmia <ophthalmology> A chronic infectious disease of the conjunctiva and cornea, producing photophobia, pain, lacrimation and blindness.
It is one of the oldest infectious diseases known to mankind, and dates back several thousand years with first documentation as early as the pharaonic era in Egypt.
The disease is associated with poor socioeconomic conditions in general: with overcrowding, poor personal and environmental hygiene and, in particular, with very limited access to water and sanitation. Trachoma has been eliminated as a blinding disease from several previously hyperendemic countries and regions, both through significant improvements in the socioeconomic status of populations and through specific control efforts.
Despite these successes, in many least developed countries of the world blinding trachoma continues to be an important public health problem. In some of the countries where trachoma was once hyperendemic, there remain residual pockets of blinding trachoma and complications, such as inturned eyelashes (trichiasis), which require eyelid surgery.
Today, the disease is found mainly in poor rural areas, including parts of central and south America, most African countries and some countries in the Eastern Mediterranean. Trachoma is still endemic in several Asian countries, but there is a lack of updated information from some major populations, e.g. In India and China.
The organism that causes this disease is Chlamydia trachomatis; a microorganism resembling both bacteria and viruses, which spreads through contact with eye discharge from the infected person (on towels, handkerchiefs, fingers, etc.) and through transmission by eye-seeking flies. Chlamydia trachomatis provokes an inflammatory reaction in the eye with formation of follicles in the conjunctiva. After years of repeated infections, the inside of the eyelids may be scarred so severely that the eyelid turns inwards with eyelashes rubbing on the eyeball. If untreated, this condition leads to blindness.
The World Health Organization is working towards global elimination of trachoma, which is responsible, at present, for at least 15% of the world's blindness. Worldwide, there are about 6 million people largely irreversibly blinded by trachoma, and an estimated 146 million cases of active disease in need of treatment, if blindness is to be prevented.
International efforts to eliminate trachoma as a blinding disease will be based on a combination of interventions known by the acronym "SAFE", which stands for Surgery for trichiasis (inturned eyelashes), Antibiotics, Facial cleanliness and Environmental improvement. These interventions will be community-targeted and will seek community involvement through the primary health care approach.
Origin: Gr. Trachoma = roughness
(07 May 1998)
granular pits Pits on the inner surface of the skull, along the course of the superior sagittal sinus, in which are lodged the arachnoidal granulations.
Synonym: foveolae granulares, pacchionian depressions.
(05 Mar 2000)
granular pneumonocytes Cuboidal cell's connected with the squamous pulmonary alveolar cell's and having in their cytoplasm lamellated bodies (cytosomes) that represent the source of the surfactant that coats the alveoli.
Synonym: granular pneumonocytes, type II cells.
(05 Mar 2000)
granular trachoma <ophthalmology> The ordinary form of trachoma marked by the presence of granulations on the conjunctiva.
Synonym: granular trachoma.
(05 Mar 2000)
granular urethritis <urology> Chronic urethritis with nodular lymphocytic infiltrations in the mucosa.
Synonym: granular urethritis.
(05 Mar 2000)
granular vaginitis A condition of cattle manifested by the appearance of small, spherical, transparent nodules in the mucosa of the vagina of cows and of the penis of bulls; the mucosa is reddened and a mucopurulent exudate appears on the affected surfaces; it is a non specific hyperplastic response of the lymphatic tissue of these areas to an irritant or an antigen.
(05 Mar 2000)
absorption band The range of wavelengths or frequencies in the electromagnetic spectrum where radiant energy is absorbed by passage through a gaseous, liquid, or dissolved substance; it is exploited for analytical purposes in colourimetry or spectrophotometry, and is usually described in terms of the wavelength where maximum absorbance occurs (i.e., lambdamax).
(05 Mar 2000)
amniotic band syndrome <syndrome> A disorder present in the newborn infant in which constriction rings or bands, causing soft tissue depressions, encircle digits, extremities, or limbs and sometimes the neck, thorax, or abdomen. They may be associated with intrauterine amputations.
(12 Dec 1998)
annular band The strands of amniotic tissue adherent to the embryo or foetus; they may cause constriction of embryonic limbs.
See: congenital amputation.
Synonym: amniotic adhesions, annular band, constriction ring, Simonart's bands, Simonart's ligaments, Simonart's threads, Streeter's bands.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • F layer
    FÃþ(ÃÖ»óÃþÀÇ Àü¸®Ãþ)
  • F2 layer
    F2Ãþ
  • Heaviside layer
    Çìºñ»çÀ̵åÃþ(´ÜÆÄ Åë½ÅÀ» °¡´ÉÄÉ ÇÏ´Â Áö»ó ¾à100ų·Î¹ÌÅÍ ³ôÀÌÀÇ ´ë±âÃþ)
  • epitazial layer
    (ÀüÀÚ)¿¡ ÇÇÅÃ¼È Ãþ
  • germ layer
    ¹è¿±
  • halfvalue layer
    ¹Ý°¡Ãþ(¹æ»ç¼±ÀÌ ¹°Áú Åë°ú½Ã,±× ÈûÀÌ ¹Ý°¨ÇÏ´Â Èí¼ö ¹°ÁúÀÇ µÎ²²)
  • layer
    ³õ´Â »ç¶÷;Ãþ
  • layer cake
    ÄÑ »çÀÌ¿¡ Å©¸² µûÀ§¸¦ ³ÖÀº °úÀÚ
  • mine layer
    ±â·Ú ºÎ¼³ÇÔ
  • nepheloid layer
    (Á¡Åä ±¸¼º¹° Å©±âÀÇ ¹Ì¼¼ÇÑ ±¤¹°ÀÌ ¶°´Ù´Ï´Â ½ÉÇØÀÇ)ÇöŹÃþ
  • band
    ²ö,¶ì,Å×,¸®º»,ÁÙ,ÇÇ´ë,º§Æ®,Çѹ«¸®ÀÇ »ç¶÷,ÀÏ´ë,´Ü,Áü½Â¶¼
  • German band
    °ü¾Ç±â¸¦ ¿¬ÁÖÇÏ¸ç °Å¸®¸¦ ´©ºñ°í ´Ù´Ï´Â ¼ÒÀμöÀÇ)°¡µÎ À½¾Ç´ë
  • S-band
    s¹êµå;5200 ¸Þ°¡Ç츣Ã÷ÀÇ ÃÊ´ÜÆÄ´ë
  • absorption band
    Èí¼ö´ë
  • band
    ²ö;¹êµå;¶ì;ÀÏ´ë;¾Ç´ë-´Ü°áÇÏ´Ù(together)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á